Structure via PubChem · Public domain (PubChem)
Pirenoxine
Sign in to savePirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts.
Chemical data
- Formula
- C16H8N2O5
- Molecular weight
- 308.24 g/mol
- IUPAC name
- 1,5-dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylic acid
- SMILES
- C1=CC=C2C(=C1)N=C3C(=CC(=O)C4=C3C(=O)C=C(N4)C(=O)O)O2
- InChIKey
- OKPNYGAWTYOBFZ-UHFFFAOYSA-N
- XLogP
- 1.3
- Polar surface area
- 105 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- carboxylic acid
- Mass
- 308.0433213559999
Show 3 more facts
- chemical formula
- C₁₆H₈N₂O₅
- canonical SMILES
- c1ccc2c(c1)nc-3c4c(cc(nc4c(=O)cc3o2)C(=O)O)O
- NCI Thesaurus ID
- C66416
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Pirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts.
A report in the Inorganic Chemistry journal showed that in liquid solutions, pirenoxine could cause decreased cloudiness of a crystallin solution produced to mimic the environment of the eye. Pirenoxine interacts with selenite or calcium ions that have been proven as factors leading to the formation of lens cataract.
Excerpted from Wikipedia’s “Pirenoxine” article, available under the CC BY-SA 4.0 licence.
Available in 6 languages
via Wikidata sitelinks · CC0